Autologous mononuclear cells showed substantial activity in patients with advanced heart failure — and even though the study ...

An autologous point-of-care cell therapy for adults with ischemic HF with reduced ejection fraction was safe and may be beneficial for select candidates, though a pivotal study did not meet its ...

My husband had left knee replacement surgery three weeks ago. He has had continuous unrelenting pain since. He was initially ...